Gestion du risque biologique en laboratoires : démarche et enjeuxGrignet, Christine ![]() Scientific conference (2013, February 27) Detailed reference viewed: 2 (0 ULg) The practical challenges of the Biosafety officer : interacting with the userGrignet, Christine ![]() in The Biosafety Professional: roles and interactions in a complex network (2008) Detailed reference viewed: 25 (9 ULg) Mise en route des animaleries GIGA souris et zébrafish: biosécurité, guide du chercheur et complémentarité avec l'Animalerie Centrale ULG - CHUDrion, Pierre ; Grignet, Christine ; Ectors, Fabien et alConference (2006, September 26) Detailed reference viewed: 272 (141 ULg) Implementing BSL II & BSL III activities in an existing facility : the case of the Animal facility of the CHU at University of Liège, Belgium "Drion, Pierre ; Grignet, Christine ![]() (2006, May 10) Detailed reference viewed: 27 (9 ULg) Attempt to enhance the suicide gene therapy agaisnt breast cancer cells by using connexin 43 geneGrignet, Christine ; ; Noël, Agnès et alin Acta Clinica Belgica (2002), 57(2), 99 Detailed reference viewed: 18 (5 ULg) The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells; Grignet, Christine ; et alin FASEB Journal (2002), 16 Endostatin and angiostatin are known as tumor-derived angiogenesis inhibitors, but their mechanisms of action are not yet completely defined. We report here that endostatin and angiostatin, delivered by ... [more ▼] Endostatin and angiostatin are known as tumor-derived angiogenesis inhibitors, but their mechanisms of action are not yet completely defined. We report here that endostatin and angiostatin, delivered by adenoviral vectors, reduced in vitro the neovessel formation in the mouse aortic ring assay by 85 and 40%, respectively. We also demonstrated in vivo that both endostatin and angiostatin inhibited local invasion and tumor vascularization of transplanted murine malignant keratinocytes, and reduced by 50 and 90% the development of highly vascularized murine mammary tumors. This inhibition of tumor growth was associated with a reduction of tumor vascularization. Expression analysis of vascular endothelial growth factor (VEGF) carried out in the mouse aortic ring model revealed a 3- to 10-fold down-regulation of VEGF mRNA expression in endostatin-treated rings. A similar down-regulation of VEGF expression at both mRNA and protein levels was also observed in the two in vivo cancer models after treatment with each angiogenesis inhibitor. This suggests that endostatin and angiostatin effects may be mediated, at least in part, by their ability to down-regulate VEGF expression within the tumor. This work provides evidence that endostatin and angiostatin act on tumor cells themselves. [less ▲] Detailed reference viewed: 69 (6 ULg) Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2’-deoxyuridine (BVDU) and its arabinosyl derivative,(E)-5-(2-bromovinyl)-1-b-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseGrignet, Christine ; ; et alin Cancer Gene Therapy (2000), 7 Detailed reference viewed: 6 (2 ULg) The role of cellular and prodrug-associated factors in the bystander effect induced by the Varicella zoster and the Herpes simplex virus thymidine kinases in suicide gene therapyGrignet, Christine ; ; et alin Cancer Gene Therapy (2000), 7 Detailed reference viewed: 6 (0 ULg) Factors involved in the bystander effect induced by Varicella zoster and Herpes simplex viral thymidine kinase suicide gene therapyGrignet, Christine ; ; et alin Journal of Gene Medicine (The) (1999), 1 Detailed reference viewed: 17 (4 ULg) Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cellsGrignet, Christine ; in Gene Therapy (1997), 4 Detailed reference viewed: 4 (0 ULg) A dicistronic vector carrying Varicella zoster virus thymidine kinase confers BVDU sensitivity to breast cancer cells in vitro and in vivoGrignet, Christine ; in Cancer Gene Therapy (1995), 2 Detailed reference viewed: 15 (7 ULg) |
||